Elad Sharon named clinical and translational director of Immunotherapy Toxicity Service at Dana-Farber

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Elad Sharon was named clinical and translational director of the Immunotherapy Toxicity Service at Dana-Farber Cancer Institute. Sharon will work to build out the research and clinical components of the program.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login